Current partner codePEPTIDESDE
NCT07276152·Not applicable·INTERVENTIONAL

Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology

Status

Recruiting

Phase

Not applicable

Enrollment

22

Locations

1

Results

Not posted

Publications

0

Study summary

What the protocol is testing.

The investigator aim to investigate wheather music modified by sonic augmentation technology can produce increasing oxytocin levels with minimal to no side effects in a highly standardized setting

Interventions

Treatment arms and agents.

OTHER

sonic augmentation technology

Participants/ patients listen to music enhanced with sonic aumentation technology

Timeline

From registration to results.

  1. First posted

    Dec 10, 2025

  2. Study start

    Jan 9, 2026

  3. Primary completion

    Aug 2026

  4. Study completion

    Aug 2026

  5. Results posted

    Not reported

  6. Registry updated

    Feb 13, 2026

Outcomes

What the study measures.

Primary outcomes

Change in oxytocin levels in healthy adults after listening to SAT enhanced music vs. placebo music

Time frame · up to 30 min

Oxytocin release in response to music enhanced with SAT in healthy participants compared to oxytocin release in response to placebo stimulation in healthy participants

Change in oxytocin levels in patients with AVP-deficiency after listening to SAT enhanced music

Time frame · up to 30 minutes

baseline is defined as 100% of the initial value, in patients with AVP-Deficiency. Any changes will be expressed as a percentage relative to this baseline. Maximum oxytocin level observed between baseline and 30 minutes will be determined.

Secondary outcomes

Area under the concentration time curve in plasma oxytocin

Time frame · up to 30 minutes

will be assessed for music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency Baseline (before lisening to SAT) to 30 min after listening to SAT

Peak change in plasma oxytocin

Time frame · up to 30 minutes

will be assessed music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency Baseline (before lisening to SAT) to 30 min after listening to SAT

Time course of plasma oxytocin levels

Time frame · up to 30 minutes

will be assessed music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency Baseline (before lisening to SAT) to 30 min after listening to SAT

Time course of plasma copeptin

Time frame · up to 30 minutes

will be assessed music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency Baseline (before lisening to SAT) to 30 min after listening to SAT

Time course of plasma cortisol

Time frame · up to 30 minutes

will be assessed music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency Baseline (before lisening to SAT) to 30 min after listening to SAT

Time course of plasma neurophysin-1

Time frame · up to 30 minutes

will be assessed music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency Baseline (before lisening to SAT) to 30 min after listening to SAT

Time course of other pituitary hormones/biomarkers

Time frame · up to 30 minutes

will be assessed music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency Baseline (before lisening to SAT) to 30 min after listening to SAT

Subjective/emotional effects assessed on numeric rating scale (NRS)

Time frame · up to 30 minutes

will be assessed music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency Baseline (before lisening to SAT) to 30 min after listening to SAT. NRS will be presented as a range from 0 to 10 marked with "not at all" on the left and "extremely" on the right. The following NAS will be used: "any effect", "good effect", "bad effect", "liking", "high", "happy", "fear", "stimulated", "feeling close to others", "concentration", "thinking", "open", "trust", "want to be with other people", "loss of sense of time", and "the boundaries between myself and my surroundings seemed to blur".

Anxiety level using State-Trait Anxiety Inventory (STAI - State)

Time frame · up to 35 minutes

will be assessed music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency. Baseline (before lisening to SAT) to 35 min after listening to SAT. Based on responses to 20 items, with scores ranging from 1 ("almost never") to 4 ("almost always"), a total score is calculated. The total trait score (STAI-T) ranges from 20 to 80, with higher scores indicating more pronounced anxiety and scores.

Frequency of specific body stress reactions using the Body Perception Questionnaire Short Form (BPQ-SF)

Time frame · up to 50 minutes

will be assessed music enhanced with SAT compared to placebo music in healthy adults and for music enhanced with SAT in patients with AVP-Deficiency Baseline (before lisening to SAT) to 50 min after listening to SAT. The BPQ-SF will be used to assess the frequency of specific body stress reactions in organs that are innervated by the autonomic nervous system (ANS). This study uses the Short Form (SF), totaling 46 items ranked from 1 (Never) to 5 (Always) to measure the frequency of specific body stress reactions. Though each unique part of the body may have its own reason for activation, the parts are linked by the ANS, a brain-body network that responds to everyday stress. Combined scores from organs throughout the body provide a measure of autonomic stress response patterns.

Eligibility

Who can take part.

Minimum age
18 Years
Maximum age
Not reported
Sex
ALL
Healthy volunteers
Yes

Part 1: Inclusion Criteria: * Adult healthy controls * No medication, except hormonal contraception Exclusion Criteria: * Participation in a trial with investigational drugs within 30 days * Illicit substance use (except for cannabis) more than 10 times in lifetime or any time within the previous two months * Consumption of alcoholic beverages \>15 drinks/week * Tobacco smoking \>10 cigarettes/day * Current or previous major psychiatric disorder (e.g., major depression, schizophrenia spectrum disorder) * Psychotic disorder in first-degree relatives * Pregnancy and breastfeeding Part 2: Inclusion Criteria: * Confirmed diagnosis of AVP-Deficiency * Age ≥ 18 years Exclusion Criteria: * Participation in a trial with investigational drugs within 30 days * Illicit substance use (except for cannabis) more than 10 times in lifetime or any time within the previous two months * Consumption of alcoholic beverages \>15 drinks/week * Tobacco smoking \>10 cigarettes/day * Current or previous major psychiatric disorder (e.g., major depression, schizophrenia spectrum disorder) * Psychotic disorder in first-degree relatives * Pregnancy and breastfeeding

Study locations

1 registered sites.

Switzerland. Showing up to 24 locations stored in the fast local snapshot.

University Hospital Basel

Basel, Switzerland

Publications

Results and literature.

No PMID-linked publications were present in this registry snapshot.

Primary links

Continue at the source.

Related trials

More studies on Vasopressin.

Related PeptideStat pages

Put the record in context.

Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.